- Investing.com
Tectonic Therapeutic, Inc., a clinical stage biotechnology company focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G-protein coupled receptors(GPCRs). It offers GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company’s pipeline products include RXFP1 agonist, which is in ongoing phase 1a and 1b for the indication of heart failure with preserved ejection fraction; GPCR antagonist for indication of hereditary hemorrhagic telangiectasia; bi-functional GPCR modulator for indication of fibrosis; and GPCR modulators. Tectonic Therapeutic, Inc. is based in Watertown, Massachusetts.
Metrics to compare | TECX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTECXPeersSector | |
---|---|---|---|---|
P/E Ratio | −12.1x | −3.8x | −0.7x | |
PEG Ratio | −0.15 | 0.24 | 0.00 | |
Price / Book | 3.9x | 2.6x | 2.6x | |
Price / LTM Sales | - | 30.2x | 3.2x | |
Upside (Analyst Target) | 25.1% | 137.4% | 43.9% | |
Fair Value Upside | Unlock | −3.1% | 6.5% | Unlock |